HIV patients should switch to long-acting antiretroviral injectable treatments sooner, study concludes
Patients who struggle to take daily HIV pills should be switched to long-acting antiretroviral (LA-ART) injectable treatments sooner to help stop the spread of HIV, a study has concluded. The paper, published in JAMA on 6 March 2025, suggests that patients who cannot control their HIV infections with pills — either because they have trouble swallowing […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.349856
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00